FDA Notices of Judgment Collection, 1908-1966

Search

Start Over Titles 156. Adulteration and misbranding of Elixir Sodium Salicylate Compound. U. S. v. Standard Pharmacal Co. Plea of nolo contendere. Fine, $25. ✖Remove constraint Titles: 156. Adulteration and misbranding of Elixir Sodium Salicylate Compound. U. S. v. Standard Pharmacal Co. Plea of nolo contendere. Fine, $25.

Refine by:

  • 156. Adulteration and misbranding of Elixir Sodium Salicylate Compound. U. S. v. Standard Pharmacal Co. Plea of nolo contendere. Fine, $25.1